Search
for
Sort by
Research 61–90 of 131
- Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Evaluation of Therapeutic Potential of a Selective 5α-reductase Inhibitor against Glioblastoma: Molecular Docking and In Vitro Insights
- Allosteric interactions prime androgen receptor dimerization and activation
- Enhanced ex vivo skin retention of bicalutamide using a nano-in-micro composite: Drug-loaded lipid vesicles in a dissolving microarray patch
- Bicalutamide: A review
- Design, synthesis and anti-tumor evaluation of novel thiohydantoin congeners as androgen receptor antagonists with in vivo study.
- Medications Mostly Associated With Ejaculatory Disorders: Assessment of the Eudra-Vigilance and Food and Drug Administration Pharmacovigilance Databases Entries
- Table_2.docx
- Table_1.docx
- Androgen sensitivity gateway to COVID‐19 disease severity
- Impact of estrogens in males and androgens in females
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Organoid technology for tissue engineering
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Coronavirus Infection and Cholesterol Metabolism
- Targeting integrin pathways: mechanisms and advances in therapy
- Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development.
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- PROTACs: A novel strategy for cancer drug discovery and development
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- The immune response to COVID‐19: Does sex matter?